Valuation: AVRA Medical Robotics, Inc.

Market Cap 750M 658M 608M 559M 1.06B 72.37B 1.07B 7.27B 2.85B 35.41B 2.82B 2.76B 122B P/E 2026 *
-62.5x
P/E 2027 * -62.5x
Enterprise Value 750M 658M 608M 559M 1.06B 72.37B 1.07B 7.27B 2.85B 35.41B 2.82B 2.76B 122B EV / Sales 2026 *
12.6x
EV / Sales 2027 * 9.98x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 51.19M
-0.18%-3.16%+0.43%+14.89% 48.71B
+0.70%-2.00%+371.81%+577.14% 38.35B
+1.72%+3.23%+8.41%+60.24% 34.53B
-1.61%-3.06%+26.75%-11.73% 34.03B
-0.58%-2.00%-0.07%+31.08% 26.77B
+0.23%-4.85% - - 15.64B
+0.48%-1.00%+71.85%+116.41% 15.08B
-2.03%+0.96%+13.12%+14.01% 14.18B
-0.31%-1.24%+18.80%-32.55% 12.73B
Average -0.50%-1.04%+63.89%+96.19% 26.67B
Weighted average by Cap. -0.04%-1.36%+75.71%+119.94%

Financials

2026 *2027 *
Net sales 59.4M 52.06M 48.13M 44.26M 83.51M 5.73B 84.85M 575M 226M 2.8B 223M 218M 9.66B 75.2M 65.91M 60.93M 56.03M 106M 7.25B 107M 729M 286M 3.55B 282M 276M 12.22B
Net income -12M -10.52M -9.72M -8.94M -16.87M -1.16B -17.14M -116M -45.57M -566M -45.06M -44.08M -1.95B -14M -12.27M -11.34M -10.43M -19.68M -1.35B -20M -136M -53.17M -661M -52.57M -51.42M -2.28B
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-